OREXIGEN THERAPEUTICS INC's ticker is OREXQ and the CUSIP is 686164302. A total of 51 filers reported holding OREXIGEN THERAPEUTICS INC in Q2 2017. The put-call ratio across all filers is 1.84 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $77,000 | -43.4% | 59,849 | -6.8% | 0.00% | – |
Q3 2017 | $136,000 | -26.9% | 64,228 | 0.0% | 0.00% | – |
Q2 2017 | $186,000 | -18.1% | 64,228 | -2.9% | 0.00% | – |
Q1 2017 | $227,000 | +99.1% | 66,120 | +0.4% | 0.00% | – |
Q4 2016 | $114,000 | -47.7% | 65,862 | +0.3% | 0.00% | – |
Q3 2016 | $218,000 | – | 65,690 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GLG LLC | 1,524,143 | $1,966,000 | 0.14% |
BVF INC/IL | 734,976 | $948,000 | 0.11% |
Old West Investment Management, LLC | 77,254 | $99,000 | 0.06% |
Telemetry Investments, L.L.C. | 64,464 | $83,000 | 0.03% |
Baupost Group | 2,226,839 | $2,873,000 | 0.03% |
NEA Management Company, LLC | 370,900 | $478,000 | 0.02% |
IFG Advisory, LLC | 49,000 | $63,000 | 0.01% |
Rock Springs Capital Management LP | 165,300 | $213,000 | 0.01% |
Virtu Financial LLC | 50,290 | $65,000 | 0.00% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 133,658 | $172,000 | 0.00% |